2025 PACC Miami | FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

2025 PACC Miami | FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

0% Complete

Course Content

FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Nov 23, 2025
Last Review
Nov 23, 2025
Expires
Nov 23, 2026

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Frank Nyanin, PharmD

Accreditation

NA

Related Courses

2026 SPS Puerto Rico | Specialty Pharmaceuticals: The Payer Perspective

2026 SPS Puerto Rico | Specialty Pharmaceuticals: The Payer Perspective

0.00 Credits
1 Chapter
Pharmacology
Free
2026 SPS Puerto Rico | Building Cell and Gene Therapy Program to Close Equity Gaps

2026 SPS Puerto Rico | Building Cell and Gene Therapy Program to Close Equity Gaps

0.00 Credits
1 Chapter
Pharmacology
Free
Explore More Courses